8
Participants
Start Date
July 31, 2013
Primary Completion Date
August 31, 2014
Study Completion Date
May 31, 2017
idelalisib
oral
lenalidomide
oral
Weill Medical College of Cornell University, New York
MedStar Georgetown University Hospital, Washington D.C.
University of North Carolina at Chapel Hill, Chapel Hill
Ohio State University Medical Center, Columbus
University of Chicago, Chicago
Washington University School of Medicine, St Louis
Collaborators (2)
National Cancer Institute (NCI)
NIH
Gilead Sciences
INDUSTRY
Celgene Corporation
INDUSTRY
Alliance for Clinical Trials in Oncology
OTHER